SEC Comment Letter 0000000000-24-003951 to GoodRx Holdings, Inc. (GDRX) (CIK 0001809519) (GDRX)
GoodRx Holdings, Inc. (GDRX) (CIK 0001809519)
Date: April 11, 2024 · CIK: 0001809519 · Accession: 0000000000-24-003951
AI Filing Summary & Sentiment
File numbers found in text: 333-278533
Letter
United States securities and exchange commission logo April 11, 2024 Karsten Voermann Chief Financial Officer GoodRx Holdings, Inc. 2701 Olympic Boulevard Santa Monica, California 90404 Re:GoodRx Holdings, Inc. Registration Statement on Form S-3 Filed April 5, 2024 File No. 333-278533 Dear Karsten Voermann: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rule 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Matthew Crispino at 202-551-3456 with any questions. Sincerely, Division of Corporation Finance Office of Technology cc: Ross McAloon
Show Raw Text
United States securities and exchange commission logo
April 11, 2024
Karsten Voermann
Chief Financial Officer
GoodRx Holdings, Inc.
2701 Olympic Boulevard
Santa Monica, California 90404
Re:GoodRx Holdings, Inc.
Registration Statement on Form S-3
Filed April 5, 2024
File No. 333-278533
Dear Karsten Voermann:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rule 461 regarding requests for acceleration. We remind you that the
company and its management are responsible for the accuracy and adequacy of their disclosures,
notwithstanding any review, comments, action or absence of action by the staff.
Please contact Matthew Crispino at 202-551-3456 with any questions.
Sincerely,
Division of Corporation Finance
Office of Technology
cc: Ross McAloon